177 related articles for article (PubMed ID: 25245669)
21. An adherent Gardnerella vaginalis biofilm persists on the vaginal epithelium after standard therapy with oral metronidazole.
Swidsinski A; Mendling W; Loening-Baucke V; Swidsinski S; Dörffel Y; Scholze J; Lochs H; Verstraelen H
Am J Obstet Gynecol; 2008 Jan; 198(1):97.e1-6. PubMed ID: 18005928
[TBL] [Abstract][Full Text] [Related]
22. Presence of a polymicrobial endometrial biofilm in patients with bacterial vaginosis.
Swidsinski A; Verstraelen H; Loening-Baucke V; Swidsinski S; Mendling W; Halwani Z
PLoS One; 2013; 8(1):e53997. PubMed ID: 23320114
[TBL] [Abstract][Full Text] [Related]
23. Preclinical Data on the
Landlinger C; Oberbauer V; Podpera Tisakova L; Schwebs T; Berdaguer R; Van Simaey L; Vaneechoutte M; Corsini L
Antimicrob Agents Chemother; 2022 May; 66(5):e0231921. PubMed ID: 35416708
[TBL] [Abstract][Full Text] [Related]
24. Treatment of bacterial vaginosis: a comparison of oral metronidazole, metronidazole vaginal gel, and clindamycin vaginal cream.
Ferris DG; Litaker MS; Woodward L; Mathis D; Hendrich J
J Fam Pract; 1995 Nov; 41(5):443-9. PubMed ID: 7595261
[TBL] [Abstract][Full Text] [Related]
25. Inhibitory activity of thymol on native and mature Gardnerella vaginalis biofilms: in vitro study.
Braga PC; Dal Sasso M; Culici M; Spallino A
Arzneimittelforschung; 2010; 60(11):675-81. PubMed ID: 21175040
[TBL] [Abstract][Full Text] [Related]
26. Optimization of culture conditions for Gardnerella vaginalis biofilm formation.
Machado D; Palmeira-de-Oliveira A; Cerca N
J Microbiol Methods; 2015 Nov; 118():143-6. PubMed ID: 26381661
[TBL] [Abstract][Full Text] [Related]
27. Antiseptic with modern wound dressings in the treatment of venous leg ulcers: clinical and microbiological aspects.
Sopata M; Kucharzewski M; Tomaszewska E
J Wound Care; 2016 Aug; 25(8):419-26. PubMed ID: 27523653
[TBL] [Abstract][Full Text] [Related]
28. Saccharomyces cerevisiae-based probiotic as novel anti-microbial agent for therapy of bacterial vaginosis.
Sabbatini S; Monari C; Ballet N; Mosci P; Decherf AC; Pélerin F; Perito S; Scarpelli P; Vecchiarelli A
Virulence; 2018 Dec; 9(1):954-966. PubMed ID: 29683763
[TBL] [Abstract][Full Text] [Related]
29. A pilot study of treatment of bacterial vaginosis with a buffering vaginal microbicide.
Harwell JI; Moench T; Mayer KH; Chapman S; Rodriguez I; Cu-Uvin S
J Womens Health (Larchmt); 2003 Apr; 12(3):255-9. PubMed ID: 12804356
[TBL] [Abstract][Full Text] [Related]
30. Identification of intrinsically metronidazole-resistant clades of Gardnerella vaginalis.
Schuyler JA; Mordechai E; Adelson ME; Sobel JD; Gygax SE; Hilbert DW
Diagn Microbiol Infect Dis; 2016 Jan; 84(1):1-3. PubMed ID: 26514076
[TBL] [Abstract][Full Text] [Related]
31. Gardnerella vaginalis outcompetes 29 other bacterial species isolated from patients with bacterial vaginosis, using in an in vitro biofilm formation model.
Alves P; Castro J; Sousa C; Cereija TB; Cerca N
J Infect Dis; 2014 Aug; 210(4):593-6. PubMed ID: 24596283
[TBL] [Abstract][Full Text] [Related]
32. Role of Gardnerella vaginalis in the pathogenesis of bacterial vaginosis: a conceptual model.
Schwebke JR; Muzny CA; Josey WE
J Infect Dis; 2014 Aug; 210(3):338-43. PubMed ID: 24511102
[TBL] [Abstract][Full Text] [Related]
33. Etiology of bacterial vaginosis and polymicrobial biofilm formation.
Jung HS; Ehlers MM; Lombaard H; Redelinghuys MJ; Kock MM
Crit Rev Microbiol; 2017 Nov; 43(6):651-667. PubMed ID: 28358585
[TBL] [Abstract][Full Text] [Related]
34. Efficacy of Antiseptic Solutions in Treatment of
Stanevičiūtė E; Builytė IU; Ridziauskas M; Besusparis J; Kirkliauskienė A; Zabulis V; Davainis L; Valiūnaitė G; Triponis V; Sirvydis V
Medicina (Kaunas); 2019 Apr; 55(4):. PubMed ID: 30991736
[No Abstract] [Full Text] [Related]
35. Human lactobacilli as supplementation of clindamycin to patients with bacterial vaginosis reduce the recurrence rate; a 6-month, double-blind, randomized, placebo-controlled study.
Larsson PG; Stray-Pedersen B; Ryttig KR; Larsen S
BMC Womens Health; 2008 Jan; 8():3. PubMed ID: 18197974
[TBL] [Abstract][Full Text] [Related]
36. Desquamated epithelial cells covered with a polymicrobial biofilm typical for bacterial vaginosis are present in randomly selected cryopreserved donor semen.
Swidsinski A; Dörffel Y; Loening-Baucke V; Mendling W; Verstraelen H; Dieterle S; Schilling J
FEMS Immunol Med Microbiol; 2010 Aug; 59(3):399-404. PubMed ID: 20497224
[TBL] [Abstract][Full Text] [Related]
37. Current Treatment of Bacterial Vaginosis-Limitations and Need for Innovation.
Bradshaw CS; Sobel JD
J Infect Dis; 2016 Aug; 214 Suppl 1(Suppl 1):S14-20. PubMed ID: 27449869
[TBL] [Abstract][Full Text] [Related]
38. Bacteramia Caused by Gardnerella Vaginalis in a Cesarean Section Patient.
Chen Y; Han X; Guo P; Huang H; Wu Z; Liao K
Clin Lab; 2018 Mar; 64(3):379-382. PubMed ID: 29739103
[TBL] [Abstract][Full Text] [Related]
39. Using an in-vitro biofilm model to assess the virulence potential of bacterial vaginosis or non-bacterial vaginosis Gardnerella vaginalis isolates.
Castro J; Alves P; Sousa C; Cereija T; França Â; Jefferson KK; Cerca N
Sci Rep; 2015 Jun; 5():11640. PubMed ID: 26113465
[TBL] [Abstract][Full Text] [Related]
40. Prevalence and distribution of Gardnerella vaginalis subgroups in women with and without bacterial vaginosis.
Janulaitiene M; Paliulyte V; Grinceviciene S; Zakareviciene J; Vladisauskiene A; Marcinkute A; Pleckaityte M
BMC Infect Dis; 2017 Jun; 17(1):394. PubMed ID: 28583109
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
